Gland Pharma Ltd - 543245 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Please see the attached Schedule of Investor meetings11-06-2021
11-06-2021
Gland Pharma to invest 270 cr on facility to produce Sputnik V
Production of the Russian vaccine will start by the third quarter of FY2208-06-2021
Gland Pharma Ltd - 543245 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Schedule of various Investor meetings scheduled07-06-2021
Gland Pharma Ltd - 543245 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Schedule of various Investor meetings scheduled29-05-2021
Gland Pharma Ltd - 543245 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Details of Investor Conference/Event the Company plan to attend29-05-2021
Gland Pharma Ltd - 543245 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Nirmal Bang Institutional Equities - Group Investor Call25-05-2021
Gland Pharma Ltd - 543245 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Video/Tele - Conference - One on One meeting with Ask Investment Managers and Axis Asset Management Company24-05-2021
Gland Pharma Ltd - 543245 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript
Earnings Call Transcript- Q4FY2121-05-2021
Gland Pharma Ltd - 543245 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Meeting with Motilal Oswal Asset Management on May 21, 202120-05-2021
Gland Pharma Q4 net profit up 34% at Rs 260.4 crore
The company had posted a net profit of Rs 194.8 crore for the corresponding period of the previous fiscal.18-05-2021